Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17


Long-Term Cause-Specific Mortality After Surgery for Women With Breast Cancer: A 20-Year Follow-Up Study From Surveillance, Epidemiology, and End Results Cancer Registries.

Escarela G, Jiménez-Balandra A, Núñez-Antonio G, Gordillo-Moscoso A.

Breast Cancer (Auckl). 2017 Jun 1;11:1178223417711429. doi: 10.1177/1178223417711429. eCollection 2017.


Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.

Tan MC, Brennan MF, Kuk D, Agaram NP, Antonescu CR, Qin LX, Moraco N, Crago AM, Singer S.

Ann Surg. 2016 Mar;263(3):593-600. doi: 10.1097/SLA.0000000000001149.


The Surveillance, Epidemiology, and End Results Cancer Survival Calculator SEER*CSC: validation in a managed care setting.

Feuer EJ, Rabin BA, Zou Z, Wang Z, Xiong X, Ellis JL, Steiner JF, Cynkin L, Nekhlyudov L, Bayliss E, Hankey BF.

J Natl Cancer Inst Monogr. 2014 Nov;2014(49):265-74. doi: 10.1093/jncimonographs/lgu021.


A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02.

Pollack A, Dignam JJ, Diaz DA, Wu Q, Stoyanova R, Bae K, Dicker AP, Sandler H, Hanks GE, Feng FY.

Clin Cancer Res. 2014 Dec 15;20(24):6379-88. doi: 10.1158/1078-0432.CCR-14-0075. Epub 2014 Oct 7.


Lessons learned from the study of 10,000 patients with soft tissue sarcoma.

Brennan MF, Antonescu CR, Moraco N, Singer S.

Ann Surg. 2014 Sep;260(3):416-21; discussion 421-2. doi: 10.1097/SLA.0000000000000869.


Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy.

Schenone AD, Luo J, Montgomery L, Morgensztern D, Adkins DR, Van Tine BA.

Cancer Med. 2014 Jun;3(3):603-12. doi: 10.1002/cam4.209. Epub 2014 Feb 27.


Modeling potential time to event data with competing risks.

Li L, Hu B, Kattan MW.

Lifetime Data Anal. 2014 Apr;20(2):316-34. doi: 10.1007/s10985-013-9279-z. Epub 2013 Sep 24.


Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients.

Giordano A, Egleston BL, Hajage D, Bland J, Hortobagyi GN, Reuben JM, Pierga JY, Cristofanilli M, Bidard FC.

Clin Cancer Res. 2013 Mar 15;19(6):1596-602. doi: 10.1158/1078-0432.CCR-12-3137. Epub 2013 Jan 22.


The impact of dose-escalated radiotherapy plus androgen deprivation for prostate cancer using 2 linked nomograms.

Stoyanova R, Pahlajani NH, Egleston BL, Buyyounouski MK, Chen DY, Horwitz EM, Pollack A.

Cancer. 2013 Mar 1;119(5):1080-8. doi: 10.1002/cncr.27857. Epub 2012 Oct 23.


Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model.

Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong YN, Uzzo RG.

J Urol. 2012 Dec;188(6):2077-83. doi: 10.1016/j.juro.2012.07.100. Epub 2012 Oct 18.


A probabilistic analysis of completely excised high-grade soft tissue sarcomas of the extremity: an application of a Bayesian belief network.

Forsberg JA, Healey JH, Brennan MF.

Ann Surg Oncol. 2012 Sep;19(9):2992-3001. doi: 10.1245/s10434-012-2345-z. Epub 2012 Apr 20.


A postoperative nomogram for local recurrence risk in extremity soft tissue sarcomas after limb-sparing surgery without adjuvant radiation.

Cahlon O, Brennan MF, Jia X, Qin LX, Singer S, Alektiar KM.

Ann Surg. 2012 Feb;255(2):343-7. doi: 10.1097/SLA.0b013e3182367aa7.


Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.

Kutikov A, Smaldone MC, Egleston BL, Manley BJ, Canter DJ, Simhan J, Boorjian SA, Viterbo R, Chen DY, Greenberg RE, Uzzo RG.

Eur Urol. 2011 Aug;60(2):241-8. doi: 10.1016/j.eururo.2011.03.029. Epub 2011 Apr 1.


Local recurrence after initial multidisciplinary management of soft tissue sarcoma: is there a way out?

Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D.

Clin Orthop Relat Res. 2010 Nov;468(11):3012-8. doi: 10.1007/s11999-010-1481-7.


Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.

Kutikov A, Egleston BL, Wong YN, Uzzo RG.

J Clin Oncol. 2010 Jan 10;28(2):311-7. doi: 10.1200/JCO.2009.22.4816. Epub 2009 Nov 23.


Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.

Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S.

Ann Surg. 2006 Sep;244(3):381-91.

Supplemental Content

Support Center